share_log
Reuters ·  May 8 07:25
Seres Therapeutics Inc - Anticipates It Has Sufficient Resources to Support Operations Through Obtaining Ser-155 Cohort 2 Data and Into Q4 of 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment